ProCE Banner Activity

CME

Expert Analysis and Conference Coverage of NLA 2023

Conference Coverage
Video

This CME-accredited video module provides highlights of NLA 2023 with key takeaways, including results from the CLEAR Outcomes trial, utilization of coronary artery calcium scores as a prognostic marker for very high‒risk ASCVD, and the need to incorporate LDL-C measurements as a performance metric.

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: June 09, 2023

Expiration: June 08, 2024

Share

Faculty

Payal Kohli

Payal Kohli, MD, FACC

Associate Adjunct Professor in Cardiology Division, Department of Medicine, Duke University
Associate Clinical Professor of Medicine, University of Colorado Anshutz
Founder and Medical Director, Cherry Creek Heart
On-Air Medical Expert, Tegna Broadcasting
Aurora, Colorado

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics

Target Audience

This program is intended for physicians—including residents and fellows—practicing in cardiology, endocrinology, and primary care who manage patients with dyslipidemia.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify key data presented at NLA 2023 on dyslipidemia

  • Translate key data on dyslipidemia presented at NLA 2023 to patient care

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Payal Kohli, MD, FACC: consultant/advisor/speaker: Amarin, Amgen, AstraZeneca, Boston Scientific, Esperion, Merck, Novartis, Zoll. 

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from June 09, 2023, through June 08, 2024:

1. Login or Sign Up for an account by clicking at the top of this page.

2. Read the target audience, learning objectives, and faculty disclosures.

3. View and study the content in its entirety.

4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.